In this interview, Dr. Christopher J. Schaber, President and CEO, discusses the Company and treating Oral Mucositis in Head and Neck cancer patients with The Sentinel’s Brett Johnson. To read the full article please visit www.onemednews.com

Dr. Christopher J. Schaber’s Interview with OneMed Sentinel
Go Back